• PCSK9 Inhibitor Passes Muster for LDL Reduction in Acute Coronary Syndrome

    6 days ago - By MedPageToday

    BOSTON - A PCSK9 inhibitor contributed extra LDL cholesterol lowering as an early add-on to standard high-intensity statins in the acute period of ST-segment elevation MI , the small EPIC-STEMI trial found.
    Between...
    Read more ...